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Abstract
Clotting systems are required in almost all animals to prevent loss of body fluids after injury. Here, we show that despite
the risks associated with its systemic activation, clotting is a hitherto little appreciated branch of the immune system.
We compared clotting of human blood and insect hemolymph to study the best-conserved component of clotting
systems, namely the Drosophila enzyme transglutaminase and its vertebrate homologue Factor XIIIa. Using labelled
artificial substrates we observe that transglutaminase activity from both Drosophila hemolymph and human blood
accumulates on microbial surfaces, leading to their sequestration into the clot. Using both a human and a natural insect
pathogen we provide functional proof for an immune function for transglutaminase (TG). Drosophila larvae with
reduced TG levels show increased mortality after septic injury. The same larvae are also more susceptible to a natural
infection involving entomopathogenic nematodes and their symbiotic bacteria while neither phagocytosis,
phenoloxidase or—as previously shown—the Toll or imd pathway contribute to immunity. These results firmly
establish the hemolymph/blood clot as an important effector of early innate immunity, which helps to prevent septic
infections. These findings will help to guide further strategies to reduce the damaging effects of clotting and enhance
its beneficial contribution to immune reactions.
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Introduction
One of the major causes of organ failure during sepsis in
humans is the systemic activation of coagulation which leads to the
widespread deposition of fibrin deposits with the result of multiple
organ failure due to reduced blood supply [1]. In contrast to these
negative effects, it is less clear whether clotting also contributes to
immunity in a positive way. The blood clot is ideally situated to
prevent not only blood loss but also dissemination of infectious
agents from the wound site [2] and has been proposed to have an
immune-protective function during a very early stage of an
infection [3–6]. Insects are injured frequently both by parasites
such as nematodes [7] and parasitic wasps [8] as well as during
copulation [9] and by predators increasing the risk of wound-
borne systemic infections. Here we show that clotting has an
important immune function by limiting the dissemination of
infections. We focused on the enzyme transglutaminase/factor
XIIIa, (TG and F XIII, respectively) which we studied both in the
model insect Drosophila melanogaster and in humans. Chemically,
TG and F XIII crosslink selected glutamines and lysines in
proteins involved in clotting leading to e-(c-glutamyl)lysine bridges
[10], which can be readily detected using artificial substrates.
Phylogenetically, TG is the sole component of clotting cascades
that has been conserved during evolution. Similarly in all species
where coagulation has been studied, TG contributes to this process
[11,12]. Finally to our knowledge TG is present in the genome of
all animals studied so far. This includes Drosophila where TG-
activity can be detected in the clot and the enzyme contributes to
clot formation [13,14]. Like in other insects, coagulation of
Drosophila hemolymph is based on an interaction between humoral
and cellular procoagulants [15]. Humoral procoagulants in
Drosophila comprise lipophorin, hexamerins, the hexamerin
receptor (also called fat body protein 1, FPB1), the clotting factor
fondue [5], and phenoloxidase, while hemolectin and tiggrin are
derived from blood cells [16]. We hypothesized that Drosophila
might be an ideal system to study the beneficial aspects of clotting
since it has an open circulatory system in which obstruction of
blood flow causes fewer problems than in vertebrates. We show
that knockdown of Drosophila TG leads to increased mortality after
injection of bacteria and in a natural infection model involving
entomopathogenic nematodes and their associated bacteria. Both
Drosophila hemolymph- and human blood clots sequester bacteria
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firmly establish clotting as part of the innate immune system and
relate it to other branches of immunity.
Results
Drosophila transglutaminase activity on microbial
surfaces
To investigate whether TG actively participates in the host
response to infection, we challenged Drosophila hemolymph with
microbes or microbe-derived immune elicitors, and then tested
whether each treatment triggered activation of TG. For this
purpose, Drosophila hemolymph was mixed with yeast cell wall
preparations (zymosan beads), and the resulting aggregates
probed with an antibody that recognizes e-(c-glutamyl)lysine
bridges. Fluorescence microscopy of the aggregates revealed a
punctate pattern mostly located at the interface between the
particles (Fig. 1A). Such aggregates were also observed when
hemolymph and zymosan were mixed in the presence of biotin-
cadaverine (B-cad), a small primary amine capable of replacing
lysine during TG-mediated crosslinking and which can serve to
mark host proteins involved in crosslinking (Fig. 1B: Zym).
Using the biotin tag, TG activity was also detectable on the
surface of both DAP peptidoglycan-containing Gram2 (Esche-
richia coli) and Lys peptidoglycan-containing Gram+ (Staphylococ-
cus aureus) bacteria (Fig. 1B: E.c and S.a) and on the surface of
entomopathogenic nematodes (Fig. 1C), which had been
incubated with hemolymph. In all cases, the pattern after B-
cad incorporation appeared to localize to small deposits on the
microbial surfaces.
Analysis of both E.coli and S.aureus lysates after incubation
with B-cad and hemolymph showed one prominent protein that
had bound to bacteria and was identified as the humoral
procoagulant hexamerin (Fig. 2A, B, see also Figure S1 for
additional controls and binding to Photorhabdus luminescens).
Using affinity purification of bacterial lysates after incubation
with the biotinylated cadaverine, we confirmed hexamerin
subunits as the major constituent of the aggregates, while less
abundant protein components included phenoloxidase and
lipophorin (Fig. 2C). These results show that upon septic
injury, TG mediates the local formation of small aggregates on
microbial surfaces, which incorporate humoral procoagulants.
This is in line with our and others’ earlier results, showing that
bacteria and zymosan beads are sequestered by the clot ([4,17]
and Fig. S2).
Figure 1. Drosophila Transglutaminase targets microbial sur-
faces. Microbes analyzed include: yeast zymosan particles (A,B: Zym),
Gram2 E. coli (E.c.) and Gram+ S. aureus (S.a.; B) and the
entomopathogenic nematode H. bacteriophora (C); A: phase contrast
exposure (left), immunocytochemistry with an antibody against e-(c-
glutamyl)lysine bridges created by TG (middle) and autofluorescence in
the red channel (right). Note the punctate deposits (arrows) on the
zymosan particles which are absent in preparations that lack
hemolymph. B-cad was used in B and C, showing TG-mediated
incorporation of B-cad into Gln-containing protein substrates. The inset
at the upper left in B is a twofold enlargement to show the punctate
labelling. All exposures were analyzed using immunofluorescence
detecting B-cad and the corresponding phase contrast exposures.
Hemolymph was omitted as a control leading to a reduction of the
signal for all microbes. The fluorescence exposure of the reaction with
zymosan lacking hemolymph (Fig. 1B, right part) was 106overexposed
to underline the significant difference in labelling efficiency between
the presence or absence of hemolymph. After omission of B-cad signals
were undetectable in most cases (not shown). Scale bars in A and B
correspond to 5mm. C: Nematodes (Heterorhabditis bacteriophora) were
incubated with B-cad and hemolymph leading to the formation of
aggregates on the cuticle (upper part). The lower part shows
autofluorescence after omission of hemolymph. The presence of GFP-
expressing P. luminescens is indicated by arrows. The scale bar
corresponds to 100mm.
doi:10.1371/journal.ppat.1000763.g001
Author Summary
One of the main functions of immune systems is to
prevent the dissemination of microbes and the resulting
sepsis. Blood clotting during sepsis has until now been
primarily regarded as harmful, leading to the formation of
widespread clots in blood vessels and as a result to organ
failure. Here we show that clotting also has a protective
function to limit and prevent infections. This is achieved by
capturing bacteria in the clot. Our infection studies were
performed in the insect model Drosophila melanogaster
where, due to the presence of an open circulatory system,
the negative effects of clotting are less pronounced. We
show that clotting of hemolymph—the insect blood
equivalent—is essential in Drosophila to prevent septic
death arising from injection of bacteria or infection with a
natural pathogen. We also show that both Drosophila
transglutaminase and its human homologue clotting
factor XIII are key enzymes for sequestration of bacteria
in the clot matrix, indicating the conserved nature of the
clot’s function in immunity. Our data are expected to lead
to a much stronger appreciation of the role of blood
clotting in innate immunity, and will guide future therapies
which target this process.
Transglutaminase in Innate Immunity
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To assess whether human F XIII has a role similar to Drosophila
TG, we performed a parallel set of experiments by incubating B-
cad with human plasma and either E. coli or S. aureus. In both
samples, B-cad was deposited onto the bacterial surface albeit
more efficiently with S. aureus as shown by fluorescence microscopy
(Fig. 3A, left). No bacterial labelling was observed when F XIII-
deficient plasma was used (Fig. 3A, right). This means that similar
to Drosophila TG, human F XIII targets microbial surfaces.
Subsequent scanning electron microscopy showed that the
functional consequence of F XIII activity is the sequestration of
bacteria by the clot matrix. Using normal plasma, both S. aureus
and E. coli were efficiently immobilized (Fig. 3B left part). With
both bacteria, sequestration was strongly reduced when F XIII-
deficient plasma was used (Fig. 3B right part) or upon addition of
monodansylcadaverine (MDC), a chemical inhibitor of TG with
effects similar to B-cad ([14], Figure S3). Like in Drosophila,T G
activity could also be detected on the surface of both E. coli and S.
aureus using an antibody with specificity for TG crosslinks (Fig. 4).
Altogether these data show that microbes are targeted by insect
TG and human F XIII leading to their sequestration in the clot.
Transglutaminase plays a role in immunity
To test the functional requirement for TG activity in innate
immunity, we used a previously described TG-RNAi line [14] with
reduced expression of TG (inset in Fig. 5A) as well as a second
independent TG knockdown line (see Methods). Aseptic injury of
TG-RNAi larvae does not have a major effect upon survival, most
likely due to the presence of redundant mechanisms [18]. In
contrast, black cells (Bc) mutants lack phenoloxidase and show both
poor clot formation [4] and strongly reduced viability upon
wounding (Fig. 5A and [18,19]). Therefore, any increased
mortality that arises upon introduction of pathogens into TG-
RNAi larvae is not expected to result from increased loss of
hemolymph. To test whether TG has a function in immunity we
next injected normal and TG knockdown Drosophila larvae with E.
coli, S. aureus and the entomopathogenic bacterium Photorhabdus
luminescens, the symbiotic bacterium of the nematode Heterorhabditis
bacteriophora (Fig. 1C, arrows). While only a marginal non-
significant effect on survival was observed using the non-
pathogenic E. coli, both the human and insect pathogen led to
Figure 2. Humoral procoagulants bind to microbial surfaces.
Lysates from E. coli (A) and S. aureus (B) were incubated in the presence
of hemolymph (Hl), B-cad or the combination of both and analyzed
using polyacrylamide gel electrophoresis. The additional band in the
samples with Hl and B-cad (asterisk) represents hexamerin. Note that in
the absence of B-cad hemolymph proteins form TG-crosslinked
aggregates, thus preventing analysis with SDS-PAGE (see methods for
further details). A similar pattern was obtained using P. luminescens
(Figure S2). C: Proteins from an E. coli lysate treated like in Fig. 1 (right
lane), were affinity-purified using streptavidin (Str-pure) and the identity
of the purified proteins determined using mass spectrometry (E.c.
shows a bacterial lysate, without hemolymph, the asterisks indicate
breakdown products of hexamerin, see Table S1 for further details).
doi:10.1371/journal.ppat.1000763.g002
Figure 3. Human F XIII sequesters bacteria in the clot matrix. A:
Plasma obtained from healthy donors (FXIII +/+) or donors with FXIII-
deficiency (FXIII 2/2) was activated with thrombin in the presence of E.
coli or S. aureus (for details see Methods). B-cad was used to visualize
FXIII-mediated incorporation at bacterial surfaces by immunofluores-
cence microscopy. Samples were also visualized by phase contrast to
show the contour of the bacteria. B: SEM exposures of clots formed with
normal plasma or FXIII-deficient plasma (the insets correspond to an 8-
fold higher magnification). Clots were formed in the absence of bacteria
(ctrl) or the presence of E. coli or S. aureus (scale bars correspond to
5 mm in A and 10 mm in B).
doi:10.1371/journal.ppat.1000763.g003
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appeared that loss of TG led to a specific immune defect in
Drosophila larvae. To test the suspected immune function more
stringently, we used the entomopathogenic nematode H. bacter-
iophora, which offers several advantages: i) this nematode is a
natural invasive insect pathogen, thus larvae are infected in a
much more reproducible way than by any artificial injection [7]; ii)
the infection includes induction of septicaemia due to the massive
release of the nematode’s symbiotic bacteria (P. luminescens), which
are essential for the nematode’s success as an entomopathogen
[20] and which we already had found to be more infectious in TG-
RNAi larvae (Fig. 5B); and iii) although both Toll and imd
pathway-dependent antimicrobial peptides are induced after
infection with H. bacteriophora, survival of larvae after nematode
infection was unaffected by mutations in either of the two
pathways [20]. This suggests that previously uncharacterized
immune mechanisms are involved in surviving nematode infec-
tions. To test the involvement of cellular procoagulants, we
included mutants lacking hemolectin [18]. To cover other immune
reactions we included mutants in additional effector pathways: Bc,
which lack active crystal cells; CG3066 mutants, which lack a
Figure 4. F XIII crosslinks are detectable on bacterial surfaces.
E. coli (A–D) and S. aureus (A9–D9) bacteria were incubated with diluted
and thrombin-activated normal (B–C9), F XIII-deficient plasma (D–D9)o r
left untreated (A–A9). Arrows in B and B9 point to plasma proteins
crosslinked to the bacteria surface. Bacteria incubated with diluted and
thrombin-activated normal (B–C9) or F XIII-deficient plasma (D–D9) were
immunostained with a mouse anti-human gold-labeled e-(c-glutamyl)
lysine-specific antibody. Arrowheads indicate crosslinking sites at the
bacterial surface and arrows at crosslinking sites of crosslinked plasma
proteins (scale bars correspond to 1 mmi nB 9 and 100 nm in D9). Please
note that no colloidal gold staining was detected when bacteria were
incubated with F XIII deficient plasma (D–D9).
doi:10.1371/journal.ppat.1000763.g004
Figure 5. Larvae with reduced TG levels show immune defects.
A: Lack of a wounding phenotype in TG knockdown lines. TG-
knockdown larvae (Act5C-Gal4.UAS-TG-RNAi: labelled TG-RNAi); a
control cross (Act5C-Gal4.w
1118: labelled TG-control); and Bc larvae
were injured and survival determined after 24 hours. The insert shows
the reduction in TG protein levels (arrowhead) detected using TG-
specific antibodies. B: TG knockdown larvae are more susceptible to
some bacteria than control larvae. TG-RNAi larvae and control larvae
were injected with P. luminescens, E. coli and S. aureus and survival
scored after 24 h. C: TG-RNAi larvae are more susceptible to nematode
infections. Larvae from the same strains like in (A) as well as the strain
used for construction of knockdown lines (w
1118); a homozygous imd
mutant (imd
Y47); a wildtype strain (Canton-S) Hml mutants (Hml);
mutants lacking CG3066 and eater mutants were infected with H.
bacteriophora. Mortality rates were determined at the indicated times
post-infection. All data points in Figs. A–C represent at least triplicates
(+/2 s.d.), all experiments were performed at 22uC, see Methods for
further details.
doi:10.1371/journal.ppat.1000763.g005
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mutants in the phagocytic receptor Eater [22].
Our experiments firstly confirm that imd mutant larvae have
similar viability after infection with nematodes compared to
control animals. In contrast, the TG-knockdown line used in
Fig. 5A as well as the second TG RNAi line (see Methods) showed
increased mortality, in line with a requirement for TG in immune
function and survival after infection (Fig. 5C). Despite the
wounding defects in Bc larvae, we found that Bc and CG3066
mutants showed normal viability after infection. We propose that,
while phenoloxidase is critical to wound healing, it is less essential
in the infection model we used here, most likely due to the
production of a P. luminescens phenoloxidase inhibitor [23]. The
cellular procoagulant hemolectin also appears dispensable for the
response towards nematodes and their bacteria. Similarly,
although we could confirm that lack of the phagocytic receptor
eater reduces uptake of P. luminescens (Figure S4), this does not
increase mortality indicating that phagoytosis too may be less
critical for the defense towards Heterorhabditis/Photorhabdus.I n
contrast to eater mutants hemocytes from TG-RNAi larvae
retained full phagocytic capacity (Figure S4). Further supporting
the immune function of the clot, we found instead that P.
luminescens is sequestered by the clot matrix (Fig. 6A). The clot’s
capacity to sequester bacteria is reduced in TG-RNAi larvae and
the clot has a more brittle appearance in line with our previous
results (Fig. 6B and C and [14]). Finally, the amount of hexamerin
that binds to microbial surfaces is reduced in TG-RNAi larvae
(Figure S5). Taken together these results firmly establish TG
activity in the clot as an effective immune mechanism that plays a
dominant role in infections such as with nematodes and their
associated bacteria.
Discussion
We have identified a previously underappreciated mechanism
in the arsenal of insect and human innate immunity. Upon contact
with hemolymph or blood, microbes are almost instantaneously
targeted by TG activity leading to formation of small aggregates
and ultimately to sequestration by the clot matrix (Fig. 7).
Glutamine and lysine residues required for TG-crosslinking may
potentially be present on different classes of proteins including: i)
hemolymph proteins, such as hexamerin, assembled at the
bacterial surface (see Fig. 2, of note hexamerins have been implied
in immunity before [24,25]); ii) bacterial proteins such as secretion
systems or other virulence factors; or iii) host-derived recognition
proteins with specificity for microbial patterns which have bound
to the bacterial surface. Interestingly some hexamerins display
lectin-like activity [26] and may act as recognition molecules in
their own right. TG-substrates on microbes are subsequently
linked to TG-substrates in the clot. We propose that in
cooperation with phagocytosis, sequestration by the clot prevents
dissemination of bacteria and systemic infections leading to a fast
Figure 6. Clots from larvae with reduced TG levels sequester fewer bacteria. A: The clot from normal larvae captures P. luminescens. A clot
bled from larvae expressing Fondue-FGP [14] was drawn out from hemolymph in the presence of GFP-expressing P. luminescens as described [16].
The clot is weakly labelled with Fondue-GFP [14]. The bacteria, which are immobilised in the clot [4] show a strong GFP signal (two sections are
shown at different magnifications, the scale bars correspond to 10 mm). B: Hemolymph clots prepared as described [4] from larvae with less TG (TG-
RNAi) and control larvae were captured and the number of sequestered bacteria determined under the microscope (P,0.01, performed in triplicates).
C: Clots from both types of larvae were also analyzed using scanning electron microscopy (note the more brittle appearance of the clot from TG-RNAi
larvae, which is also observed after addition of MDC: see [14]). The scale bar corresponds to 10 mm, the arrowheads indicate bacteria which have been
incorporated into the clot.
doi:10.1371/journal.ppat.1000763.g006
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we observe on microbial surfaces (Fig. 1) might play a role in
immunity in their own right. Irrespective of the exact mechanism,
TG- dependent activity appears to be the dominant immune
mechanism during massive infiltration of bacteria such as after
release from the nematode gut (Fig. 5C). In this case clot formation
occurs in the absence of injury and is most likely identical to the
formation of nodules to which it has been likened previously based
on histological observations [27]. Future work will help to
elucidate the exact route of Photorhabdus after their release into
the hemolymph and whether TG contributes more to resistance or
tolerance towards the bacteria [28,29].
We observe that although TG activity can be detected on all
microbial surfaces tested and targets the same hemolymph
proteins on E. coli, S. aureus (Fig. 2A, B) and P. luminescens (Figure
S3), TG knockdown lines show increased susceptibility to only
some microbes (Fig. 3B). Further work will be required to show
whether there are any qualitative differences between the
aggregates that bind to different microbes and whether these
explain the different efficacy of TG-mediated crosslinking.
Regardless of the evolutionary variability of TG substrates in
blood/hemolymph, TG itself is widely conserved and has been
shown to contribute to clot formation in almost every species
where clotting has been studied in any detail [15,30]. For several
animal models and for humans, evidence has been provided that
the clot has a function in entrapping microbes [17,31,32]. Here we
show for the first time its functional importance in a natural
infection model. The mode in which TG contributes to immunity
appears to be evolutionarily conserved providing yet another
example for the successful use of insect models to decipher
mechanisms that contribute to human immunity. TG activity has
to be kept local in both Drosophila and humans but in contrast to
insects with their open circulatory system systemic activation of
TG in humans bears the additional risk of obstructing small blood
vessels. Until now, focus on this negative aspect might have
prevented full appreciation of the beneficial aspects of clotting.
Our results fully agree with the observation that certain
polymorphisms in clotting factors such as factor V Leiden which
leads to a hypercoagulable state appear to be under balancing
selection [33]. Epidemiological studies in humans and studies in
animal models indicate that in addition to preventing bleeding
more efficiently, Factor V Leiden might also protect from severe
sepsis [34]. Future therapeutic strategies will thus have to aim at
enhancing the helpful local effects of clotting while preventing its
detrimental systemic effects. This appears even more vital in the
light of the fact that we observe strong support for TG’s immune
function when using pathogenic bacteria such as S. aureus or P.
luminescens.
Methods
Fly stocks
Flies were kept under standard conditions. The Drosophila strains
included: a TG knockdown strain (Stock ID: 7356R-2, National
Institute of Genetics Fly Stock Center, [14]). A second TG-RNAi
strain produced independently with a different construct (Stock
ID: 26101, Construct ID: 10774 from Vienna collection) showed
similar reduced survival at all time points studied (24, 48 and
72 hours; p,0.05) although stronger effects were observed with
7356R-2 which was used for further studies. Crosses between TG-
RNAi and Act5C-Gal4 show no morphological defects at 22uC and
survive wounding equally well as control larvae (Fig. 4B); at higher
temperatures, larvae appear normal although pupae displayed
decreased eclosion rates. Additional strains include: Canton-S, Black
cells (Bc), and a P-element insertion mutant in CG3066 [28,35]
and imd
Y47. Driver lines were Act5C-Gal4 and ppl-GAL4 (kindly
provided by B. Lemaitre, Lausanne).
Histochemistry with anti-crosslink antibody
Hemolymph from ten w
1118 larvae was incubated at a 50 fold
dilution for five minutes at room temperature with Drosophila
Ringer’s solution containing the phenoloxidase inhibitor phenyl-
thiourea (PTU) and Zymosan A (at a final concentration of 3610
5
beads/ml). The preparation was analyzed with the e-(c-glutamyl)
lysine-specific antibody (at a dilution of 1:100, Covalab mab0012).
No signal was detected with secondary antibodies alone (not
shown) or when hemolymph was omitted (Fig. 1A).
Sequestration of bacteria by Drosophila clot
To analyze the sequestration of bacteria to fly clot, 10 larvae
were bled into 2ml of bacterial suspension (P.luminescens expressing
GFP) as described (hanging drop method, [4]). The clot was
captured on an electron microscopy grid, washed 5 times with PBS
and subsequently mounted on a new slide and the number of
bacteria/square counted using fluorescence microscopy.
Incorporation of B-cad into microbial surfaces
Ten w
1118 larvae were bled as described [14] followed by
addition of either washed Zymosan A beads (SIGMA), or bacterial
suspensions (S. aureus SH1000 or E. coli MG 1655, kind gifts from
Ha ˚kan Steiner, Stockholm). After addition of biotincadaverine
(Zedira) to 5 mM the preparation was incubated for 80 minutes at
room temperature, centrifuged at 4000 g for 5 minutes, washed 3
times with Drosophila Ringer’s solution and visualised using
Figure 7. Hypothetical mechanisms for transglutaminase-
mediated sequestration of microbes by the clot matrix.
Transglutaminase crosslinks humoral procoagulants such as hexamerin
and Fondue leading to their incorporation into the clot. Additional
possible TG-substrates on microbes include microbial surface proteins
such as secretion systems and recognition proteins with specificity for
microbial patterns.
doi:10.1371/journal.ppat.1000763.g007
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TG-mediated crosslinking, B-cad reduces aggregation of zymosan
beads). Control preparations without biotincadaverine, which
were prepared the same way as above showed labelling of just a
few dead bacteria (see Fig. 1 for additional controls).
Infection of D. melanogaster larvae with H. bacteriophora
Infection of D. melanogaster larvae with infective juveniles was
modified according to Hallem et al. [20]. Infective juveniles from
wildtype H. bacteriophora (H222, isolated from Pouzdr ˇany, Czech
Republic, kindly provided by Dr. Z. Mra ´c ˇek, Institute of
Entomology, C ˇeske ´ Bude ˇjovice, Czech Republic) were collected
after multiplying on G. mellonella larvae and used for infection
according to [20] with the exception that the nematodes were
applied using tissue paper at a multiplicity of 100 nematodes/
larva. All experiments were performed at 22uC.
TG antibody synthesis
Anti-TG guinea pig polyclonal antibody was produced by
Invitrogen Corp. (Carlsbad, CA). Amino acid residues 757–773
were selected as the antigen (NH2-CQPNGSHRSSNIIRRRTD).
The cysteine at the N-terminus is inserted to allow for conjugation
with keyhole limpet hemocyanin. 50 mg of conjugate in Incom-
plete Freund’s Adjuvant was injected into each of two guinea pigs
at weeks 3, 5, and 8. Each guinea pig was ‘‘boosted’’ with 200 mg
in Complete Freund’s Adjuvant at week 10, and 100 mgi n
Incomplete Freund’s Adjuvant at week 11. Exsanguination was
carried out at week 21.
Interactions of human F XIII with microbial surfaces in
plasma
S. aureus SH1000 or E. coli MG 1655 bacteria were grown
overnight in Todd-Hewitt-Broth or LB-Medium and washed 36
with sterile PBS. Human plasma obtained from healthy donors
(purchased from the blood bank at Lund University Hospital,
Lund, Sweden) or from donors with F XIII-deficiency (F
XIII2/2 plasma, purchased from George King BioMed Inc.,
Overland Park, KS, USA) was incubated with thrombin (Sigma,
St. Louis, MO, USA) and bacteria. The peptide H-1998 (H-Gly-
Pro-Arg-Pro-NH2)( B a c h e m ,B u b e n d o r f ,S w i t z e r l a n d )w a s
added to avoid clotting. Finally, biotincadaverine (Zedira,
Darmstadt, Germany) was addedt o5m Ma n dp r e p a r a t i o n s
were incubated for 1.5 h rotating at 37uC. After centrifugation
at 8000 rpm and washing 36 with PBS streptavidin-Cy3
(Sigma, St. Louis, MO, USA) was added and the samples were
incubated for 1 h rotating at room temperature. After 36
washing with PBS the preparations were mounted in glycerol
and analyzed with a fluorescence microscope (Nikon, Tokyo,
Japan) using a 1006objective. Control samples without biotinca-
daverine were prepared the same way as described above.
Preparation of clots
Overnight cultures of S. aureus SH1000 or E. coli MG 1655 were
grown in Todd-Hewitt-Broth or LB-Medium and washed 36with
sterile PBS. 50 ml of human plasma obtained from healthy donors
or donors with F XIII-deficiency were incubated for 60 sec. at
37uC in a coagulometer (Amelung, Lemgo, Germany). 50 mlo f
bacterial solution were added followed by 60 sec. incubation at
37uC. Clotting was initiated by adding 100 ml of Hemoclot-
Thrombin (Hyphen Bio-Med, Neuville-sur-Oise, France). Control
clots without bacteria were generated by adding 100 mlo f
Hemoclot-Thrombin to 100 ml of human normal or F XIII2/2
plasma. All clots were fixed in 2.5% glutaraldehyde in 0.15 M
cacodylate buffer (pH 7.2) and analyzed by scanning electron
microscopy. Samples were dehydrated with a graded series of
ethanol, critical-point dried with CO2, and sputter coated with
gold before examination in a JEOL JSM-350 scanning electron
microscope (JEOL Ltd., Tokyo, Japan) operated at 5 kV
accelerating voltage and a magnification of 2000. (as described
elsewhere [36]). In some experiments the transglutaminase
inhibitor monodansylcadaverine (MDC) (Sigma, St. Louis, MO,
USA) was added to a final concentration of 5 mM to the plasma
prior to the incubation with bacteria and the initiation of clotting.
Negative staining
E. coli or S. aureus were grown overnight and 2610
9 bacteria per
ml were incubated with human plasma obtained from healthy
donors or patients with FXIII-deficiency. Plasma (diluted 1:100 in
13 mM sodium citrate to avoid clotting) and bacteria were
incubated for 30 Min at 37uC in the presence of thrombin and a
mouse anti-human gold-labeled N e gamma glutamyl Lysine [153-
81D4] antibody (GeneTex Inc., Irvine, CA, USA), recognizing the
crosslinking site of FXIII. Subsequently samples were adsorbed to
400 mesh carbon-coated copper grids for 1 minute, washed briefly
with two drops of water, and stained with two drops of 0.75%
uranyl formate. The grids were rendered hydrophilic by glow
discharge at low pressure in air. Samples were observed in a Jeol
1200 EX transmission electron microscope operated at 60kV
accelerating voltage as described earlier [37]. Control experiments
were performed in the absence of bacteria and the antibody.
Purification of proteins with a B-cad tag
Proteins containing a biotin tag were purified from sonicated
bacterial lysates which had been treated as described above (see:
Incorporation of B-cad into microbial surfaces) using streptavidin-
containing magnetic beads (Dynal) according to the manufactur-
er’s instruction except that Drosophila Ringer’s solution was used for
washes. Proteins were eluted using SDS-PAGE loading buffer and
separated using PAGE.
MALDI-TOF mass spectrometry analysis and protein
identification
After affinity purification on streptavidin proteins (see Fig. 2C)
were identified as described [16]. The hexamerin bands in Figs. 2A
and B were in sufficient amounts to identify them without further
purification. The results of the complete identification are
summarised in Table S1.
Statistical analysis
Samples from 5 infection experiments using w
1118 were initially
tested positive for normality (Lilliefors test). Strain mortality was
subsequently compared using ANOVA followed by Tukey’s test
for significance. The results were confirmed using a log-Rank test
on survival curves.
Supporting Information
Figure S1 Humoral procoagulants bind to E. coli (A) and P.
luminescens (B) surfaces. Bacterial lysates were incubated in the
presence of hemolymph (Hl), B-cad or the combination of both or
with B-cad alone (in the case of E. coli) and analyzed using
polyacrylamide gel electrophoresis. The additional band in the
samples with Hl and B-cad (asterisks) represents hexamerin. Note
that in the absence of B-cad hemolymph proteins form TG-
crosslinked aggregates, thus preventing analysis with SDS-PAGE
(see methods for further details).
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Figure S2 Zymosan particles are sequestered by the clot matrix.
A drawout (A and [16] was performed in the presence of zymosan
and the resulting fibers analyzed under fluorescence microscopy
(B) and phase contrast (C). Zymosan beads visible due to
autofluorescence are indicated by arrowheads, fat body debris
released during wounding is also incorporated (*).
Found at: doi:10.1371/journal.ppat.1000763.s002 (1.27 MB TIF)
Figure S3 Sequestration of bacteria is inhibited by the TG
inhibitor monodansylcadaverine (MDC). Clots were prepared as
described (see Fig. 3B) in the presence and absence of MDC alone
or in the presence of either E. coli or S. aureus SH1000. The scale
bar corresponds to 10 mm.
Found at: doi:10.1371/journal.ppat.1000763.s003 (3.75 MB TIF)
Figure S4 Hemocytes from eater mutants but not from TG-
RNAi larvae show reduced phagocytosis of P. luminescens. The
percentage of hemocytes that had taken up bacteria was counted
essentially as described [22] after mixing with GFP-expressing P.
luminescens and incubation for 30 minutes. Note that in contrast to
eater mutants (p=8.1610
28 compared to controls: TG-ctrl),
hemocytes from TG-RNAi lines show normal phagocytic capacity.
Found at: doi:10.1371/journal.ppat.1000763.s004 (0.11 MB TIF)
Figure S5 Hexamerin binding to microbes is reduced in TG-
RNAi larvae. Proteins binding to zymosan in the presence of
biotincadaverine were analyzed using polyacrylamide-gelelectro-
phoresis. Both complete zymosan beads (2) as well as beads after
pullout [5] on peanut agglutinin (PNA, +) are shown for a control
cross (TG-contr) and a TG-knockdown (TG-RNAi). Note that the
amount of hexamerin is reduced after TG-RNAi for both
treatments.
Found at: doi:10.1371/journal.ppat.1000763.s005 (0.31 MB TIF)
Table S1 Identification of microaggregate proteins.
Found at: doi:10.1371/journal.ppat.1000763.s006 (0.05 MB
DOC)
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